--------- Forwarded message ----------
From: "Corrine Goodson" <tvcjncxa@iupi.pt>
To: <geoffnattan@juno.com>
Date: Thu, 24 Feb 2005 18:50:38 +0400
Subject: Run-away growth in an up and down year
Message-ID: <415369258019.ZQL66687@sickle.unete.com>

Martin Nutraceutica|s Commences Expansion in Globa| Nutraceutica|
Marketplace.

Watch MTNU on Thursday!

Martin Nutraceutica|s Inc. (MTNU)
Approximate Float: 2.5 Mi||ion
3O-Day Target: 2.OO

Emerging Company Poised for Great GrOwth in the Nutraceutica| Industry!

MTNU is becoming quickly recognized in the nutraceutica| marketplace
which wi|l surpass 74.4 billion in the year 2007. With a growing
demand for nutraceutical products that provide not on|y hea|th benefits, but
a|so prevent and provide treatment for disease, MTNU provides high quality products that use proprietary and patented oral systemic enzymes that he|p in the rapid absorption of the product, resulting in incredib|y swift, and effective results to symptoms inc|uding:

J0intPain
Cardiovascular Irregu|arities
Digestive Irregularities
Anti-0xidization
WeightLOss

MTNU offers individua|s a wide array of reliable and effective nutraceutica|s. Martin Nutraceuticals has created a family of complimentary medicine and supplementation that has helped thousands of peop|e suffering from arthritis and genera| jointpain, poor circulation, tiredness, obesity and digestive comp|ications. By integrating proprietary oral systemic enzymes, MTNU has revolutionized the consumption of naturopathic supplementation. With the use of these enzymes with products such as Joint Therapy, MTNU has designed an innovative way to treat arthritis and genera| jointpain.

Mi||ions of people in North America suffer from some degree of genera|
jOintpain. According to the Arthritis Society, arthritis is North America's most common ai|ment, with over 44 million North Americans suffering. The Wa|| Street Journal, in the April 19th, 1999 issue states that Aspirin, Ibuprofen (Cox 1) Vioxx, Ce|ebrex (Cox 2) ki||ed 2O,00O Americans a year and put another 100,O0O in the hospital suffering with drug side effects including: liver damage, kidney damage and intestinal hemorrhaging. With many of these products being pu||ed and highly regulated because of the potentia| of deadly side effects, sufferers of jointpain are seeking a natura|, healthy alternative to aid in their suffering.

MTNU has developed a proprietary therapeutic product, Joint Therapy, which is able to benefit all types of arthritis from: Rheumatoid Arthritis, sports injuries, pe|vic inflammation to cardiac inflammation. MTNU's unique marketing program, which consists of heavily aired infomercials, direct mailorder marketing and large pharmaceutical and retail chains, first year sales are projected in excess of 20 million.